EUVIMEDOpdag EUVIMED
ÜbersichtsarbeitOpen access · CC BY-NC 4.0

Environmental impact of inhaled medicines: A Thoracic Society of Australia and New Zealand position statement

Danielle F Wurzel iD, Brett D Montgomery, Natalie Anderson, Elena K Schneider-Futschik, Johnson George, Sinthia Bosnic-Anticevich iD, Emily Stone iD, Robert J Hancox iD, James Fingleton iD, Stephanie Kuek, Helen Tope, John Blakey iD

Respirology · 2025

DOI: 10.1111/resp.14852 ↗

At a glance

Übersichtsarbeit in Respirology, 2025. Written by Danielle F Wurzel and 11 co-authors. Institution: Allergy and Lung Health Unit, School of Population and Global Health, University of Melbourne, Melbourne, Victoria, Australia. Major MEDLINE topics: Pulmonary Disease, Chronic Obstructive, Asthma, Environment. Cited 12 times so far (Crossref); 87 references. The full text is freely available (open access, CC BY-NC 4.0).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Globally, more than 1.2 billion inhalers are purchased for asthma and chronic obstructive pulmonary disease (COPD) annually. In Australia and New Zealand, pressurized metered dose inhalers (pMDIs) are the leading delivery device prescribed and pMDI salbutamol can be purchased over the counter in Australia. These inhalers are a major contributor to healthcare related greenhouse gases. This is due to the propellants that they currently contain which have extremely high global warming potential (GWP). In this position paper, we report the findings of a Thoracic Society of Australia and New Zealand (TSANZ) working group on the environmental impact of inhaled respiratory medicines. We reviewed the use of inhaled medicines in Australia and New Zealand and their contribution to climate change and other environmental degradation. We propose strategies for health professionals and consumers to reduce environmental impact in the management of airway diseases. These include accurate diagnosis to avoid unnecessary treatment, better disease control to minimize the need for reliever therapy and actively choosing inhaler devices with lower environmental impacts when clinically appropriate. Inhaler selection should be tailored to the individual, aiming to achieve the best possible clinical outcome. Choosing an appropriate inhaler for an individual involves consideration of factors such as dexterity, inspiratory capacity and cost. In our current climate emergency and with the availability of lower carbon alternatives, health professionals should also consider environmental impact. image

Subjects

MeSH terms (MEDLINE)

Pulmonary Disease, Chronic ObstructiveAsthmaEnvironmentHumansNew ZealandAustraliaAdministration, InhalationMetered Dose InhalersClimate ChangeSocieties, MedicalNebulizers and VaporizersBronchodilator Agents

Author keywords

COPDair pollutionasthmaclimate changeclinical respiratory medicine

Substances

Bronchodilator Agents

Authors and institutions

  • Allergy and Lung Health Unit, School of Population and Global Health, University of Melbourne, Melbourne, Victoria, Australia.
  • Royal Children's Hospital and Murdoch Children's Research Institute, Melbourne, Victoria, Australia.
  • General practice, Medical School, University of Western Australia, Perth, Western Australia, Australia.
  • Perioperative Care Program, Perioperative Medicine Team, Telethon Kids Institute, Nedlands, Western Australia, Australia.
  • Medical School, Curtin University, Perth, Western Australia, Australia.
  • Division of Emergency Medicine, Anaesthesia and Pain Medicine, Medical School, The University of Western Australia, Perth, Western Australia, Australia.

ORCID profiles: Danielle F Wurzel, Sinthia Bosnic-Anticevich, Emily Stone, Robert J Hancox, James Fingleton, John Blakey

Cite

APA

Wurzel, D. F., Montgomery, B. D., Anderson, N., Schneider-Futschik, E. K., George, J., Bosnic-Anticevich, S., Stone, E., Hancox, R. J., Fingleton, J., Kuek, S., Tope, H., & Blakey, J. (2025). Environmental impact of inhaled medicines: A Thoracic Society of Australia and New Zealand position statement. Respirology. https://doi.org/10.1111/resp.14852

Vancouver

Wurzel DF, Montgomery BD, Anderson N, Schneider-Futschik EK, George J, Bosnic-Anticevich S, et al. Environmental impact of inhaled medicines: A Thoracic Society of Australia and New Zealand position statement. Respirology. 2025. doi:10.1111/resp.14852

BibTeX
@article{Wurzel2025,
  author = {Wurzel, Danielle F and Montgomery, Brett D and Anderson, Natalie and Schneider-Futschik, Elena K and George, Johnson and Bosnic-Anticevich, Sinthia and Stone, Emily and Hancox, Robert J and Fingleton, James and Kuek, Stephanie and Tope, Helen and Blakey, John},
  title = {Environmental impact of inhaled medicines: A Thoracic Society of Australia and New Zealand position statement},
  journal = {Respirology},
  year = {2025},
  doi = {10.1111/resp.14852}
}
Start for free →